Danske Bank’s Legend Biotech LEGN Stock Holding History

Danske Bank’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Buy	8,000 +7,100	+789%	+$192K	﹤0.01%	650
2026 Q1	$16.3K	Sell	900 -6,700	-88%	-$128K	﹤0.01%	750
2025 Q4	$165K	Buy	7,600 +2,000	+36%	+$57.3K	﹤0.01%	695
2025 Q3	$183K	Buy	5,600 +1,300	+30%	+$48K	﹤0.01%	802
2025 Q2	$153K	Sell	4,300 -3,100	-42%	-$100K	﹤0.01%	803
2025 Q1	$251K	Hold	7,400	–	–	﹤0.01%	915
2024 Q4	$241K	Hold	7,400	–	–	﹤0.01%	945
2024 Q3	$361K	Sell	7,400 -600	-8%	-$32K	﹤0.01%	923
2024 Q2	$354K	Hold	8,000	–	–	﹤0.01%	884
2024 Q1	$449K	Buy	+8,000	New	+$482K	﹤0.01%	891

Other funds holding LEGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

DCP

Davern Capital Partners Ny, New York $587M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Danske Bank's LEGN Position: Q2 2026 in Review

Danske Bank increased its Legend Biotech (LEGN) stake by 789% in Q2 2026, buying an estimated $192K and bringing the position to 8,000 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Danske Bank first reported a position in LEGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $449K in Q1 2024. 156 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Danske Bank held 8,000 shares of Legend Biotech worth $231K as of Q2 2026.
Danske Bank bought 7,100 Legend Biotech shares in Q2 2026, an estimated $192K.
Legend Biotech made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #650 holding.
Danske Bank first reported a position in Legend Biotech in Q1 2024 and has held it in 10 quarters since.
Danske Bank's Legend Biotech position peaked at $449K in Q1 2024.
156 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.